PapersPMID:40329862
Randomized Placebo Controlled Clinical Study of Dill (Anethum Graveolens L.) in Thyroiditis and Nodular Goiter Patients.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- three capsules per day for 90 days
- Population, every finding
- Patients with benign thyroid nodules (thyroiditis and nodular goiter); dill group against placebo group, 90 days
What moved
How to read these marks →“Compared to the control group, the dill group had significantly decreased TSH (P = .009), fT4 (P < .001), anti-TPO (P = .001), CRP (P < .001) levels and nodule sizes (P < .001), which reached normal values.”
- Decreases serum free thyroxine (FT4)
very limited
- Decreases C-reactive protein concentration
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with benign thyroid nodules, thyroiditis and nodular goiter (abstract only); dried and ground dill (Anethum graveolens L.), plant part not stated, in hydroxypropyl methylcellulose capsules
- Participants
- 68
- Comparator
- placebo
- Duration
- 90 days
- Endpoints measured
- 10